Latest Commercialisation News

Nimy Resources has reported exceptional high-grade gallium results from its Block 3 drilling campaign in Western Australia, setting the stage for a maiden JORC resource estimate in the coming quarter.

Algorae Pharmaceuticals has advanced its AI-driven drug discovery platform into preclinical validation through a strategic collaboration with the Peter MacCallum Cancer Centre, while progressing its therapeutic pipeline and commercial leadership.

EMVision Medical Devices has secured ethics approvals for two pivotal clinical studies and received a $400,000 milestone payment, marking significant progress toward commercialising its portable First Responder brain scanner.

Carnegie Clean Energy's subsidiary has secured two milestone payments totaling approximately AUD 520,000, marking significant progress in deploying its wave energy technology at a key European test site.

Neometals has reported a maiden Mineral Resource Estimate for its Ironclad gold deposit at Barrambie and signed a non-binding MoU with Rio Tinto to advance its lithium processing technology, alongside progress in battery recycling plant commissioning.

Condor Energy’s maiden independent resource estimate confirms a multibillion barrel prospective oil resource offshore Peru, supported by enhanced seismic data and ongoing gas commercialisation studies.

Elevate Uranium prepares to ship its U-pgrade™ Pilot Plant to Namibia, aiming to validate its innovative uranium beneficiation process through a large-scale trial processing 60 tonnes of ore.

BPH Energy’s June quarter update highlights ongoing legal proceedings over the PEP-11 permit, promising progress in AI-driven brain monitoring technology, and strategic moves toward hydrogen production facilities, supported by a robust cash reserve.

NuEnergy Gas Limited reports a mixed quarter with ongoing exploration costs and a strategic push towards early gas sales, while actively seeking new funding to sustain operations.

NuEnergy Gas Limited has completed drilling two wells at its Tanjung Enim PSC in Indonesia, advancing its early gas sales initiative targeting 1 million cubic feet per day. The company is finalizing a major gas sales agreement pending government approval.

PainChek Limited has raised A$7.5 million through a strongly supported placement to accelerate its US market entry following anticipated FDA clearance and expand its innovative AI pain assessment technology internationally.

Clarity Pharmaceuticals has completed a $203 million institutional placement at a premium, bolstering its cash reserves to nearly $288 million and positioning the company to advance pivotal clinical trials and commercial preparations for its cancer-fighting radiopharmaceuticals.